{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:22:01Z","timestamp":1783405321148,"version":"3.54.6"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T00:00:00Z","timestamp":1778976000000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cancer MoonshotSM Initiative"},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN261201500003I"],"award-info":[{"award-number":["HHSN261201500003I"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN26100039"],"award-info":[{"award-number":["HHSN26100039"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Public Access Policy"},{"name":"Official Date of Publication"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Meningiomas exhibit clinical heterogeneity. Radiotherapy (RT) remains the only adjuvant therapy, but tumor-control is variable, and biomarkers are limited. NRG\/RTOG-0539 is the first prospective phase 2 trial to stratify meningioma patients for adjuvant RT based on clinical risk. Here, we apply modern molecular tools to this cohort and identify correlates of RT response.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Tumor tissue from 100 RTOG-0539 patients was profiled using DNA methylation arrays, RNA sequencing, and whole-exome sequencing. Recurrence scores, Molecular Groups, gene expression, and copy number alterations were compared across clinical groups and between RT responders and non-responders; non-response was defined as progression or death within 3 years.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Modern grading criteria, including brain invasion, TERT mutation, CDKN2A\/B deletion, and 1p\/1q status, would reclassify 10% of tumors and alter treatment group assignment in 7%. Non-responders to RT exhibited more frequent 1p and 14q loss, and more copy number alterations. Transcriptomic and epigenetic profiling revealed immune-related signatures in responders and cell cycle\u2013related pathways in non-responders, several of which overlapped with targets of vorinostat, a histone deacetylase inhibitor previously validated in aggressive meningioma models. The Proliferative Molecular Group was an independent predictor of post-RT recurrence in multivariable analysis, outperforming WHO grade.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Multi-omic analysis of the NRG\/RTOG-0539 cohort shows that updated WHO grading criteria, incorporating molecular and cytogenetic features, improve risk stratification. However, molecular classification, particularly the Proliferative group, remains an independent and stronger predictor of RT response. These findings support integrating molecular biomarkers alongside modern grading frameworks to guide treatment and trial design in meningioma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Trial Information<\/jats:title>\n                    <jats:p>NCT00895622.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/neuonc\/noag081","type":"journal-article","created":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:04:36Z","timestamp":1778760276000},"page":"1727-1740","source":"Crossref","is-referenced-by-count":0,"title":["Modern molecular profiling recontextualizes the NRG\/RTOG 0539 trial and reveals hidden high-risk and radiotherapy-resistant meningiomas"],"prefix":"10.1093","volume":"28","author":[{"given":"Leeor S","family":"Yefet","sequence":"first","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Department of Neurologic Surgery, Mayo Clinic , Rochester, Minnesota,","place":["USA"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P","family":"Landry","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Leland","family":"Rogers","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Utah Cancer Specialists , West Jordan, Utah,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8998-7443","authenticated-orcid":false,"given":"Justin Z","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-6590","authenticated-orcid":false,"given":"Jeff","family":"Liu","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Patil","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6685-1970","authenticated-orcid":false,"given":"Chloe","family":"Gui","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Ajisebutu","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1390-1361","authenticated-orcid":false,"given":"Yosef","family":"Ellenbogen","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Wei","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7321-6775","authenticated-orcid":false,"given":"Olivia","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic , Rochester, Minnesota,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Mansouri","sequence":"additional","affiliation":[{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Szot","sequence":"additional","affiliation":[{"name":"Biospecimen Research Group, Frederick National Laboratory for Cancer Research , Frederick, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2558-0537","authenticated-orcid":false,"given":"Richard C","family":"Jordan","sequence":"additional","affiliation":[{"name":"Department of Oral Pathology, Pathology and Radiation Oncology, UCSF Medical Center-Mount Zion , San Francisco, California, (R.C.J.)","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8256-1906","authenticated-orcid":false,"given":"Igor J","family":"Barani","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Barrow Neurological Institute , Phoenix, Arizona,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4672-6213","authenticated-orcid":false,"given":"Michael W","family":"Straza","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Medical College of Wisconsin , Milwaukee, Wisconsin, (M.W.S.)","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4060-0874","authenticated-orcid":false,"given":"Hui-Kuo G","family":"Shu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The Winship Cancer Institute of Emory University , Atlanta, Georgia,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9383-0000","authenticated-orcid":false,"given":"Kelli B","family":"Pointer","sequence":"additional","affiliation":[{"name":"Dartmouth Hitchcock Medical Center\/Dartmouth Cancer Center , Lebanon, New Hampshire,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7160-9778","authenticated-orcid":false,"given":"Grant","family":"Hunter","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Intermountain Medical Center , Salt Lake City, Utah,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5114-4432","authenticated-orcid":false,"given":"Valerie","family":"Panet-Raymond","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, McGill University Health Centre , Montreal, Quebec,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-3912","authenticated-orcid":false,"given":"Wenyin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Thomas Jefferson University Hospital , Philadelphia, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8667-0782","authenticated-orcid":false,"given":"Haley K","family":"Perlow","sequence":"additional","affiliation":[{"name":"University Hospitals Seidman Cancer Center, Case Western Reserve University , Cleveland, Ohio,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5579-1725","authenticated-orcid":false,"given":"Brian D","family":"Kavanagh","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, UCHealth University of Colorado Hospital , Aurora, Colorado,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0010-9172","authenticated-orcid":false,"given":"Tyler","family":"Gunter","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, OU Health Stephenson Cancer Center , Oklahoma City, Oklahoma,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1399-9904","authenticated-orcid":false,"given":"Clifford","family":"Robinson","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Siteman Cancer Center at Washington University , Saint Louis, Missouri,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L","family":"Pugh","sequence":"additional","affiliation":[{"name":"NRG Oncology Statistics and Data Management Center , Philadelphia, Pennsylvania,","place":["USA"]},{"name":"American College of Radiology , Philadelphia, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0733-3337","authenticated-orcid":false,"given":"Adam P","family":"Dicker","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Thomas Jefferson University Hospital , Philadelphia, Pennsylvania,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4812-5713","authenticated-orcid":false,"given":"Minesh P","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Miami Cancer Institute , Miami, Florida,","place":["USA"]},{"name":"Department of Radiation Oncology, Florida International University , Miami, Florida,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5392-8721","authenticated-orcid":false,"given":"Arnab","family":"Chakravarti","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Ohio State University Comprehensive Cancer Center , Columbus, Ohio,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farshad","family":"Nassiri","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5119-7550","authenticated-orcid":false,"given":"Kenneth","family":"Aldape","sequence":"additional","affiliation":[{"name":"Center for Cancer Research, National Cancer Institute , Bethesda, Maryland,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2002-5313","authenticated-orcid":false,"given":"Gelareh","family":"Zadeh","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Surgery, University of Toronto , Toronto, Ontario,","place":["Canada"]},{"name":"Department of Neurologic Surgery, Mayo Clinic , Rochester, Minnesota,","place":["USA"]},{"name":"Princess Margaret Cancer Centre, University Health Network , Toronto, Ontario,","place":["Canada"]},{"name":"MacFeeters Hamilton Neuro-Oncology Program, Princess Margaret Cancer Centre, University Health Network and University of Toronto , Toronto, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,15]]},"reference":[{"key":"2026070701512305800_noag081-B1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noad149","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2016-2020","volume":"25","author":"Ostrom","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026070701512305800_noag081-B2","doi-asserted-by":"publisher","first-page":"djv377","DOI":"10.1093\/jnci\/djv377","article-title":"TERT promoter mutations and risk of recurrence in meningioma","volume":"108","author":"Sahm","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"2026070701512305800_noag081-B3","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-020-02188-w","article-title":"CDKN2A\/B homozygous deletion is associated with early recurrence in meningiomas","volume":"140","author":"Sievers","year":"2020","journal-title":"Acta Neuropathol"},{"key":"2026070701512305800_noag081-B4","doi-asserted-by":"publisher","first-page":"2046","DOI":"10.1002\/(sici)1097-0142(19990501)85:9&lt;2046::aid-cncr23&gt;3.0.co;2-m","article-title":"\u201cMalignancy\u201d in meningiomas: a clinicopathologic study of 116 patients, with grading implications","volume":"85","author":"Perry","year":"1999","journal-title":"Cancer"},{"key":"2026070701512305800_noag081-B5","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1001\/jamaoncol.2025.0329","article-title":"Chromosome 1p loss and 1q gain for grading of meningioma","volume":"11","author":"Landry","year":"2025","journal-title":"JAMA Oncol"},{"key":"2026070701512305800_noag081-B6","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1093\/neuonc\/noae170","article-title":"cIMPACT-NOW update 8: clarifications on molecular risk parameters and recommendations for WHO grading of meningiomas","volume":"27","author":"Sahm","year":"2025","journal-title":"Neuro Oncol"},{"key":"2026070701512305800_noag081-B7","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41586-021-03850-3","article-title":"A clinically applicable integrative molecular classification of meningiomas","volume":"597","author":"Nassiri","year":"2021","journal-title":"Nature"},{"key":"2026070701512305800_noag081-B8","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1093\/neuonc\/noae242","article-title":"Development and validation of a molecular classifier of meningiomas","volume":"27","author":"Landry","year":"2025","journal-title":"Neuro Oncol"},{"key":"2026070701512305800_noag081-B9","doi-asserted-by":"publisher","first-page":"eabm6247","DOI":"10.1126\/sciadv.abm6247","article-title":"Multiple approaches converge on three biological subtypes of meningioma and extract new insights from published studies","volume":"8","author":"Bayley","year":"2022","journal-title":"Sci Adv"},{"key":"2026070701512305800_noag081-B10","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41588-022-01061-8","article-title":"Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities","volume":"54","author":"Choudhury","year":"2022","journal-title":"Nat Genet"},{"key":"2026070701512305800_noag081-B11","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/S1470-2045(17)30155-9","article-title":"DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis","volume":"18","author":"Sahm","year":"2017","journal-title":"Lancet Oncol"},{"key":"2026070701512305800_noag081-B12","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/neuonc\/noab213","article-title":"A molecularly integrated grade for meningioma","volume":"24","author":"Driver","year":"2022","journal-title":"Neuro Oncol"},{"key":"2026070701512305800_noag081-B13","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1200\/JCO.21.00784","article-title":"Integrated molecular-morphologic meningioma classification: a multicenter retrospective analysis, retrospectively and prospectively validated","volume":"39","author":"Maas","year":"2021","journal-title":"J Clin Oncol"},{"key":"2026070701512305800_noag081-B14","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.ijrobp.2019.11.028","article-title":"High-risk meningioma: initial outcomes from NRG oncology\/RTOG 0539","volume":"106","author":"Rogers","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026070701512305800_noag081-B15","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","article-title":"Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539","volume":"129","author":"Rogers","year":"2018","journal-title":"J Neurosurg"},{"key":"2026070701512305800_noag081-B16","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/neuonc\/noac137","article-title":"Low-risk meningioma: initial outcomes from NRG oncology\/RTOG 0539","volume":"25","author":"Rogers","year":"2023","journal-title":"Neuro Oncol"},{"key":"2026070701512305800_noag081-B17","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1038\/s41591-024-03167-4","article-title":"Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma","volume":"30","author":"Wang","year":"2024","journal-title":"Nat Med"},{"key":"2026070701512305800_noag081-B18","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1093\/neuonc\/noae236","article-title":"Validation and next-generation update of a DNA methylation-based recurrence predictor for meningioma: a multicenter prospective study","volume":"27","author":"Landry","year":"2025","journal-title":"Neuro Oncol"},{"key":"2026070701512305800_noag081-B19","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1038\/s41591-024-02995-8","article-title":"Prediction of DNA methylation-based tumor types from histopathology in central nervous system tumors with deep learning","volume":"30","author":"Hoang","year":"2024","journal-title":"Nat Med"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noag081\/68302755\/noag081.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/7\/1727\/68302755\/noag081.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/28\/7\/1727\/68302755\/noag081.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:51:28Z","timestamp":1783403488000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/28\/7\/1727\/8680210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,15]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,3,15]]},"published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noag081","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7]]},"published":{"date-parts":[[2026,3,15]]}}}